Gamunex-c 10 gram/100 ML vial 100ML
Ended Awarded Last action
- Contract number
- SPE2DR26F21DA
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $22,819
Award facts
- Contract value 100% obligated
- $22,818.96 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $22,818.96 firm fixed-price delivery order to AmerisourceBergen Drug Corp for GAMUNEX-C 10 Gram/100 ML Vial (100 ML) on January 22, 2026, with an ultimate completion date of February 12, 2026. The contract involves no set-aside designation, indicating competitive procurement. Performance will take place at the vendor's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's parent company, Cencora, Inc., which holds a substantial Indefinite Delivery Contract with DLA Troop Support Medical valued at up to $999,999,999.00 through December 2031. This prime IDC serves as the primary vehicle for delivering a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.
GAMUNEX-C is an intravenous immunoglobulin (IVIG) product used to treat primary immunodeficiency disorders and other immune conditions requiring antibody replacement therapy. AmerisourceBergen's role as a critical pharmaceutical distributor ensures timely delivery of this specialized medication to military treatment facilities and federal healthcare systems. The company's extensive portfolio of federal contracts demonstrates its capability to fulfill complex medical procurement requirements across multiple therapeutic domains while maintaining firm fixed pricing for federal customers.
Quick answers
Who was awarded contract SPE2DR26F21DA?
SPE2DR26F21DA was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 22, 2026.
How much is contract SPE2DR26F21DA worth?
The government has obligated $22,819 on SPE2DR26F21DA.
Is contract SPE2DR26F21DA an order under another contract?
Yes. SPE2DR26F21DA is a delivery order under SPE2DR25D3301, an indefinite delivery contract.
Was contract SPE2DR26F21DA competed?
The extent of competition for SPE2DR26F21DA was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award